In cancer, TGF-β1 plays contrasting roles; inhibiting cellular transformation and tumor progression in the early stages of cancer, while stimulating tumor growth in the later stages of the disease by either promoting epithelial-to-mesenchymal transition (EMT), inducing angiogenesis, or triggering immunosuppression [14]. This evidence concerns the gene TGFB1 and neoplasm.